Bank of America Corp DE lifted its stake in shares of Kimberly-Clark Corporation (NASDAQ:KMB - Free Report) by 3.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,881,641 shares of the company's stock after purchasing an additional 219,742 shares during the period. Bank of America Corp DE owned approximately 2.07% of Kimberly-Clark worth $755,398,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. Godfrey Financial Associates Inc. acquired a new position in shares of Kimberly-Clark in the fourth quarter worth about $25,000. Motiv8 Investments LLC acquired a new position in Kimberly-Clark in the 4th quarter worth approximately $31,000. Entrust Financial LLC purchased a new position in Kimberly-Clark during the 4th quarter worth approximately $32,000. Edmond DE Rothschild Holding S.A. purchased a new position in Kimberly-Clark during the 2nd quarter worth approximately $32,000. Finally, Ancora Advisors LLC acquired a new stake in Kimberly-Clark during the 2nd quarter valued at $32,000. 76.29% of the stock is owned by hedge funds and other institutional investors.
Trending Headlines about Kimberly-Clark
Here are the key news stories impacting Kimberly-Clark this week:
- Positive Sentiment: Kimberly-Clark is reportedly expected to secure European Commission approval for the Kenvue transaction during the initial review phase. A smoother-than-expected regulatory process could reduce uncertainty surrounding the approximately $40 billion acquisition. Kimberly-Clark expected to win EU approval for Kenvue in phase 1 - report
- Positive Sentiment: Reports that Kimberly-Clark is willing to sell assets to resolve EU competition concerns suggest the company is actively advancing the Kenvue deal. Approval would give KMB access to Kenvue’s consumer-health portfolio, including well-known brands, although the concessions could reduce some strategic benefits. Kimberly-Clark readies EU remedies in bid for Kenvue deal, sources say
- Neutral Sentiment: Market coverage continues to focus on the company’s valuation and the financial complexity of combining Kimberly-Clark with Kenvue. Analysts note that KMB’s share-price discount may look attractive, but the acquisition makes it more difficult to assess the stock’s underlying value. Kimberly-Clark valuation analysis
- Negative Sentiment: Any asset disposals required for EU approval could dilute the deal’s expected strategic advantages and add uncertainty over proceeds, timing and integration. Investors are also weighing the transaction against Kimberly-Clark’s recent earnings miss, which has contributed to weakness in the shares. Kimberly-Clark Moves to Clear EU Hurdle with Kenvue Asset Sales
Analyst Ratings Changes
KMB has been the subject of several recent analyst reports. TD Cowen raised their target price on Kimberly-Clark from $96.00 to $104.00 and gave the stock a "hold" rating in a research report on Wednesday, August 5th. UBS Group increased their price objective on Kimberly-Clark from $115.00 to $116.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 5th. Freedom Capital upgraded Kimberly-Clark from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 4th. Weiss Ratings raised Kimberly-Clark from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, July 28th. Finally, Barclays upped their target price on Kimberly-Clark from $101.00 to $115.00 and gave the company an "equal weight" rating in a report on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $117.36.
Check Out Our Latest Stock Analysis on KMB
Kimberly-Clark Trading Down 0.4%
NASDAQ KMB opened at $98.68 on Wednesday. The company has a current ratio of 0.91, a quick ratio of 0.69 and a debt-to-equity ratio of 3.45. Kimberly-Clark Corporation has a 1-year low of $92.42 and a 1-year high of $126.98. The firm's fifty day simple moving average is $108.09 and its 200-day simple moving average is $103.23. The company has a market capitalization of $32.82 billion, a PE ratio of 16.78, a price-to-earnings-growth ratio of 4.54 and a beta of 0.25.
Kimberly-Clark (NASDAQ:KMB - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.01 by ($0.21). Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The firm had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.22 billion. During the same period in the previous year, the business posted $1.92 EPS. Kimberly-Clark's revenue for the quarter was up .6% on a year-over-year basis. As a group, sell-side analysts anticipate that Kimberly-Clark Corporation will post 7.38 earnings per share for the current fiscal year.
Kimberly-Clark Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 2nd. Investors of record on Friday, September 4th will be given a dividend of $1.28 per share. This represents a $5.12 annualized dividend and a yield of 5.2%. The ex-dividend date of this dividend is Friday, September 4th. Kimberly-Clark's dividend payout ratio (DPR) is presently 87.07%.
About Kimberly-Clark
(
Free Report)
Kimberly-Clark Corporation is a global manufacturer of personal care and consumer tissue products. The company develops and markets products designed to support personal hygiene, health and well-being in households, healthcare settings and workplaces.
Its portfolio includes well-known brands such as Huggies diapers and training pants, Kleenex facial tissues, Cottonelle toilet paper and wipes, Scott toilet paper and paper towels, Kotex feminine care products, and Depend and Poise incontinence care products.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.